The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT ID: NCT01707056
Last Updated: 2021-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-09-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will help determine the safest and most effective way for adults to take their thyroid medication and will guide medical practitioners in how to counsel their patients when they prescribe thyroid hormone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics
NCT03102177
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001730
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972
Effects of L-carnitine on Hypothyroidism
NCT01769157
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
NCT02959827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Using methods similar to those used in previous studies, this study will measure thyroid function tests in approximately 10-20 subjects (18-60 years of age) over a 6 hour period of time after taking their thyroid medication with the specified study beverage for a 6 week period. Subjects will be randomized to water, black coffee, coffee with milk, and black tea as four specified study beverages, with water serving as the control beverage. Each subject will be recruited to participate with each study beverage for a 6 week period of time in a total of four consecutive 6 week periods. Blood draws will occur at the end of each 6 week period on test days 1, 2, 3, and 4. The coffee will represent the most common household coffee brand, Folgers. Thyroid function tests with each beverage will be compared to thyroid function tests with water to determine if thyroid medication absorption is impaired by coffee, coffee with milk, or tea.
This study will help determine the safest and most efficacious way for adults to take their thyroid medication and will guide medical practitioners in how to counsel their patients when they prescribe thyroid replacement therapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Black coffee
Synthroid will be administered with 12 ounces of black coffee for a period of 6 weeks.
Black Coffee
Taking Synthroid with 12 ounces of black coffee for 6 weeks.
Coffee with Milk
Synthroid will be administered with 12 ounces of coffee and 2 ounces of 2% milk for a period of 6 weeks.
Coffee with Milk
Taking Synthroid with 12 ounces of black coffee and 2 ounces of 2% milk for a period of 6 weeks.
Black Tea
Synthroid will be administered with 12 ounces of black Lipton tea for a period of 6 weeks.
Black Tea
Taking Synthroid with 12 ounces of black tea for a period of 6 weeks.
Water
Synthroid will be administered with 12 ounces of water for a period of 6 weeks.
Water
Taking Synthroid with water for a period of 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Black Coffee
Taking Synthroid with 12 ounces of black coffee for 6 weeks.
Coffee with Milk
Taking Synthroid with 12 ounces of black coffee and 2 ounces of 2% milk for a period of 6 weeks.
Black Tea
Taking Synthroid with 12 ounces of black tea for a period of 6 weeks.
Water
Taking Synthroid with water for a period of 6 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Undetectable baseline TSH
* Not willing to drink coffee, coffee with milk, or black tea
* Age less than 18 or greater than 60 years old
* Taking generic thyroid hormone (levothyroxine) and not brand-name Synthroid
* Dose of thyroid medication has been recently changed (less than 3 months ago)
* Currently receiving treatment for gastroesophageal reflux disease, gastritis, stomach or intestinal cancer, inflammatory bowel disease, or H. pylori
* Taking cholestyramine resin, colestipol hydrochloride, sucralfate, iron sulphate, aluminum containing antacids, activated charcoal, raloxifene, and herbal remedies
* History of previous gastric or small intestine surgery
* Diagnosis of kidney or liver disease, congestive heart failure, anemia, biliary disease, pancreatitis
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Georgetown University
OTHER
Medstar Health Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dorota Krajewski, MD
Role: PRINCIPAL_INVESTIGATOR
MedStar Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Georgetown University Hospital
Washington D.C., District of Columbia, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
MedStar St. Mary's Hospital
Leonardtown, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Benvenga S, Bartolone L, Pappalardo MA, Russo A, Lapa D, Giorgianni G, Saraceno G, Trimarchi F. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008 Mar;18(3):293-301. doi: 10.1089/thy.2007.0222.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-338
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.